Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Perindopril arginine/Amlodipine versus Valsartan/Amlodipine antihypertensive strategies: Efficacy and safety in mild to moderate hypertensive patients. A randomised, double blind 6-month study followed by 8-month open label long-term follow-up with Perindopril arginine/Amlodipine

Next Previous
X
Search
Trial Profile

Perindopril arginine/Amlodipine versus Valsartan/Amlodipine antihypertensive strategies: Efficacy and safety in mild to moderate hypertensive patients. A randomised, double blind 6-month study followed by 8-month open label long-term follow-up with Perindopril arginine/Amlodipine

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 27 Aug 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Perindopril/amlodipine (Primary) ; Amlodipine/valsartan; Indapamide; Valsartan
  • Indications Essential hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors IRIS

    • Most Recent Events

    • 14 Jul 2019 Trial has been completed in UK, according to European Clinical Trials Database record.
    • 15 Jun 2015 Results of clinical trial program (4 studies) presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.
    • 01 Sep 2012 Actual end date (1 Sep 2012) added as reported by ISRCTN: Current Controlled Trials.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top